The largest database of trusted experimental protocols
Sourced in United States

The Caki-2 is a laboratory equipment designed for cell culture applications. It is a cell line that is commonly used in scientific research. The Caki-2 cell line is derived from human renal cell carcinoma.

Automatically generated - may contain errors

25 protocols using caki 2

1

Culturing Human Renal Carcinoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human clear cell renal carcinoma cell line (Caki-2) was used (American Type Culture Collection, Manassas, VA). Caki-2 cells were grown in McCoy’s 5A medium with L-glutamine (Gibco/Invitrogen, Carlsbad, Ca) with 10% fetal bovine serum (FBS; Sigma-Aldrich, Saint Louis, MO) and 1x penicillin-streptomycin solution (Sigma-Aldrich, Saint Louis, MO). The cells were maintained at 37°C in 5% CO2 atmosphere. For all the experiments, Caki-2 cells were seeded into 75cm2 bottles, 6- or 12-well culture plates at density 13x103 cells/cm2, 24h before transfection. Three independent in vivo experiments were performed in triplicate.
+ Open protocol
+ Expand
2

Cell Line Maintenance for Renal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human clear cell type RCC cell lines Caki-1 and Caki-2 were purchased from the American Type Culture Collection. Caki-1 and Caki-2 were maintained with McCoy’s 5A medium (Invitrogen) containing 10% fetal bovine serum (FBS). The other human RCC cell lines, UMRC-3 and UMRC-6, were kindly gifted by Dr. P. Black (Vancouver Prostate Centre, UBC). UMRC-3 and UMRC-6 were maintained in MEM medium (Invitrogen) containing 10% FBS and L-glutamine. The human renal proximal tubular epithelial cell line HK-2 was kindly provided by Dr. C. Du (Vancouver Prostate Centre, UBC). HK-2 cells were cultured in DMEM/Ham’s F12 (Invitrogen) supplemented with 10% FBS and glutamine. Immortalized human umbilical vascular endothelial cells (HUVECs) were obtained from Dr. C. Du and maintained with EBM-2 medium (Lonza) containing EGM-2 SingleQuots (Lonza). All cells were cultured at 37°C in a humid atmosphere with 5% CO2. Mycoplasma contamination was tested. For all in vitro studies, cell lines were passaged for a maximum of 2 months.
+ Open protocol
+ Expand
3

Human Renal Cell Carcinoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Caki-2, ACHN and RCC4(+) cells are the VHL-positive human RCC cell lines. 786-O and RCC4(-) cells are the VHL-negative human RCC cell lines. 786-O, ACHN, and Caki-2 cells were purchased from Summit Pharmaceuticals International (Tokyo, Japan). RCC4(+) and RCC4(-) cells were obtained from KAC Co. Ltd. (Kyoto, Japan). The Caki-2 and 786-O cells were routinely cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum, 50 mg/ml penicillin G and 50 mg/ml streptomycin (Invitrogen, Tokyo, Japan), at 37 °C in a 5% CO2–95% room air. The RCC4(+) and RCC4(-) cells were routinely cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum, 50 mg/ml penicillin G and 50 mg/ml streptomycin (Invitrogen, Tokyo, Japan), at 37 °C in a 5% CO2–95% room air.
+ Open protocol
+ Expand
4

Kidney Cancer Cell Line Coculture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human kidney cancer cell lines 786‐O and Caki‐2 and the non‐malignant human kidney cell line HEK293T were purchased from ATCC (Manassas, VA, USA) and maintained in basal media (RPMI for 786‐O and Caki‐2, DMEM for HEK293T) supplemented with 10% FBS and 1% gentamicin–tyrosine solution (Invitrogen, Eugene, OR, USA) in a humidified incubator set to 37°C and 5% CO2. For coculture experiments, the three cell lines were split into 35‐mm dishes (Becton Dickinson) and incubated for 2 days to reach 80–90% confluence. Transwell inserts (0.4‐μm pore size; Corning, Corning, NY, USA) were then placed into the wells and 5 × 106 PBMCs from healthy volunteers were added to each Transwell insert. After 18 h, PBMCs were collected and lysed with Buffer RLT Plus with beta‐ME (RNeasy Plus Mini Kit; Qiagen, Venlo, Netherlands) and subjected to RNA extraction and qRT‐PCR.
+ Open protocol
+ Expand
5

Transfection of miR-1251-5p and NPTX2 in Renal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipofectamine®2000 was employed to transmit miR-1251-5p mimic-NC, sh-NC, sh-NPTX2, oe-NC, and oe-NPTX2 into A498 as well as Caki-2 (Invitrogen, USA). GENEray created all of the combinations (Shanghai, China).
+ Open protocol
+ Expand
6

Establishment and Characterization of RCC Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The primary RCC cell lines TINCA1, TINCA3, TINCA7, and MAR were established from surgically resected tumor specimens. The MAR cell line was kindly provided by Dr. Richard Childs (National Institutes of Health). The RCC cell lines ACHN, Caki-2, A498 and the myelogenous leukemia cell line K562 were obtained from the American Type Culture Collection (ATCC). Caki-1 and 786-O cells were kindly provided by Prof. Barbara Seliger (Martin Luther University Halle-Wittenberg, Germany). All cell lines were maintained in RPMI1640 or DMEM (Thermo Fisher Scientific) supplemented with 10% FBS (Thermo Fisher Scientific). The TINCA cell lines were cultured with 20% FBS. Cell lines (ACHN, A498, Caki-2, and 786-O) were authenticated using the AmpFLSTR Identifiler PCR Amplification Kit (Thermo Fisher Scientific).
+ Open protocol
+ Expand
7

Renal Cell Carcinoma Tissue Collection

Check if the same lab product or an alternative is used in the 5 most similar protocols
RCC tissue and adjacent normal tissue were obtained from 40 RCC patients (median age 55 years, male:female 3:2) receiving nephrectomy at our hospital. The resected tumors were snap-frozen in liquid nitrogen and then stored at -80°C. Tumor stage was defined following the TNM classification standard of American Joint Committee on Cancer. Experimental protocols were approved by the ethics committees of Huaihe Hospital of Henan University. Written informed consent was obtained from all RCC patients prior to tissue use.
HK2 cells were obtained from the American Type Culture Collection (Manassas, VA, USA) and cultured in keratinocyte serum-free medium containing 0.05 mg/mL bovine pituitary extract and 5 ng/mL human recombinant EGF (Thermo Fisher Scientific, Waltham, MA, USA). Human RCC cells (769P, 786O, ACHN, A498, Caki2) were purchased from the China Center for Type Culture Collection (Wuhan, China). 769P and 786O cells were cultured in RPMI 1640 medium supplemented with 10% FBS (Thermo Fisher Scientific). ACHN cells were maintained in MEM-EBSS (HyClone, Logan, UT, USA) containing 10% FBS. A498 cells were maintained in the MEM-EBSS supplemented with 10% FBS and 1% inessential amino acids (Thermo Fisher Scientific). Caki2 cells were grown in modified McCoy’s 5A medium (Thermo Fisher Scientific) containing 10% FBS. All cultures were kept in a humidified atmosphere with 5% CO2 at 37°C.
+ Open protocol
+ Expand
8

Investigating OGT Regulation in Renal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human normal renal tubular epithelial HK-2 and RCC 786-O, A498, ACHN, and CAKI-2 cell lines were purchased from the Cell Bank of Type Culture Collection of Chinese Academy of Sciences (CCCAS, Shanghai, China). 786-O cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM, Thermo Fisher Scientific, Waltham, MA, USA). A498, ACHN, and CAKI-2 cells were cultured in RMPI 1640 (Thermo Fisher Scientific), while HK-2 cells were cultured in Keratinocyte Medium (KM, ScienCell, Carlsbad, CA, USA). All cell culture media were supplemented with 10% Fetal Bovine Serum (FBS, Hyclone, Logan, UT, USA), and cells were cultured at 37°C with 5% CO2.
The lentivirus expressing shRNA against OGT was produced by Jiman Co. (Shanghai, China). 786-O and A498 cells were infected with LV-sh-OGT or LV-sh-NC and selected by puromycin (Sigma–Aldrich, St. Louis, MO, USA). The expression levels of OGT and O-GlcNAc were examined at the RNA and protein levels.
+ Open protocol
+ Expand
9

Culturing Human Renal Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human renal cancer cell lines (786-O, 769-P, CAKI-1, CAKI-2, and ACHN) and human renal tubular epithelial cells (HK-2) were purchased from the Chinese Academy of Sciences (Shanghai, China). All cell lines were cultured at 37°C with 5% CO2. CAKI-1 and CAKI-2 were cultured in McCoy's 5A Medium (Gibco, Waltham, MA, USA); 786-O and 769-P were cultured in RPMI-1640 medium (Gibco, Grand Island, NY, USA). HK-2 was cultured in DMEM. The medium was supplemented with 10% fetal bovine serum (FBS) (Gibco, Grand Island, NY, USA).
+ Open protocol
+ Expand
10

Generating Pyk2-modified Renal Cell Carcinoma Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human RCC cell lines (A498, ACHN, CAKI-2, OS-RC-2, 769P and 786-O) and the normal kidney cell line HK-2 were obtained from the Shanghai Institute of Life Sciences Cell Resource Center (Shanghai, China). OS-RC-2, 769P and 786-O cell lines were cultured in RPMI modified medium (GE Healthcare Life Sciences, Logan, UT, USA), and A498 and ACHN cell lines were cultured in minimum essential medium (Eagle; Corning Inc., Corning, NY, USA). The CAKI-2 cell line was cultured in McCoy's 5A medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA), and the HK-2 cell line was cultured in DMEM (GE Healthcare Life Sciences). All media were supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (Gibco; Thermo Fisher Scientific, Inc.), according to the American Type Culture Collection. All cell cultures were maintained at 37°C in a humidified atmosphere with 5% CO2. According to the expression of Pyk2 in RCC cell lines, we selected ACHN cells to generate Pyk2 knockdown cells and A498 cells to generate stable Pyk2 overexpression cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!